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. Recurrence of UTI, which occurs in ~25-30% of women [5] [6] [7] [8] , has made treating infections of the urinary tract particularly challenging, and treatment options are limited owing to the emergence of multidrug-resistant strains [9] [10] [11] [12] [13] . UTIs are clinically subdivided into uncomplicated and complicated infections. Uncomplicated UTIs typically occur in healthy individuals, and include those that affect the lower urinary tract (cystitis) or those that affect the upper urinary tract (pyelonephritis), whereas complicated UTIs typically affect patients who have a compromised urinary tract or host defence 2 . The majority of complicated UTIs are catheter-associated, and are associated with increased morbidity and mortality. Complicated UTIs can also be associated with other predisposing conditions including urinary retention due to neurological diseases, renal failure and transplantation, urinary obstruction, and pregnancy 2 . A variety of Gram-positive and Gram-negative bacteria, as well as fungi, have been implicated in infections of the urinary tract. The most common cause of both uncomplicated and complicated UTIs is uropathogenic Escherichia coli (UPEC) 14, 15 . Other common infectious agents include Staphylococcus saprophyticus, Klebsiella spp, Enterococcus faecalis, Group B Streptococcus (GBS), Pseudomonas aeruginosa, Staphylococcus aureus, and Candida spp 2, 14 . The urothelium is the first line of defence against UTIs, as epithelial cells provide both a physical and an immunological barrier to avert infection and trigger activation of the innate immune system. Given the variety of pathogens that can infect the urinary tract, research has focused on the immune response during the establishment and clearance of UTIs, which is important to understand the mechanisms of recurrent infections and also to identify alternative treatment strategies in light of increasing antimicrobial resistance. The innate immune system, consisting of pattern recognition receptors (PRRs) and their downstream effectors, helps to protect against pathogens in the urinary tract [16] [17] [18] [19] . PRRs are germline encoded and recognize conserved microbial structures known as pathogen-associated molecular patterns (PAMPs), or danger-associated molecular patterns (DAMPs) released by damaged host cells. The PRRs can be classified into two major families based on their localization. The membrane-bound Toll-like receptors (TLRs) and C-type lectin receptors (CLRs) primarily survey the extracellular space. Conversely, intracellular pathogens are sensed by cytoplasmic receptors, including the RIG-I-like receptor (RLR), the AIM2-like receptor (ALR), and the nucleotide-binding domain and leucine-rich repeat containing receptors (NLRs) [19] [20] [21] [22] [23] . Expression of the NLRs NLRP3 and NLRC4 has been previously reported in the bladder epithelium 24, 25 , and further studies confirmed these results and reported Abstract | Urinary tract infections (UTIs) cause a huge burden of morbidity worldwide with recurrent UTIs becoming increasingly frequent owing to the emergence of antibiotic-resistant bacterial strains. Interactions between the innate and adaptive immune responses to pathogens colonizing the urinary tract have been the focus of much research. Inflammasomes are part of the innate immune defence and can respond rapidly to infectious insult. Assembly of the multiprotein inflammasome complex activates caspase-1, processes proinflammatory cytokines IL-1β and IL-18, and induces pyroptosis. These effector pathways, in turn, act at different levels to either prevent or resolve infection, or eliminate the infectious agent itself. In certain instances, inflammasome activation promotes tissue pathology; however, the precise functions of inflammasomes in UTIs remain unexplored. An improved understanding of inflammasomes could provide novel approaches for the design of diagnostics and therapeutics for complicated UTIs, enabling us to overcome the challenge of drug resistance.
the expression of NLRs NLRP1, 6, 7, and 12, and ALR family member AIM2 (REF. 26 ). The location and expression of these receptors in the urothelium indicates that the bladder has the potential to initiate immune responses to a wide variety of uropathogens, in addition to being involved in sterile inflammatory responses. NLRs and some ALRs form important components of inflammasomes -multimeric protein complexes consisting of apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1 that assemble in response to PAMPs and DAMPs.
Despite pivotal roles of inflammasomes in infection, our understanding of inflammasome signalling in specific infections is imperfect, and is mainly limited to a few well-studied microorganisms. Although UTI is a major cause of morbidity and mortality worldwide, the function of inflammasome signalling in UTIs has only recently been suggested. In this Review, we describe our present knowledge of the NLRP3 complex followed by current and emerging evidence on the effect of inflammasomes and their downstream effectors in the pathogenesis of UTIs. Several pathogens capable of colonizing the urinary tract activate inflammasomes in macrophages, but not all uropathogens have been investigated in the context of inflammasome activation in the urinary tract. Thus, we will limit the discussion to studies of three important uropathogens: E. coli, Group B Streptococcus and P. aerugi nosa, in which direct or indirect effects on the urinary tract have been reported. Understanding the role of the inflammasomes might also lead to new diagnostic and therapeutic approaches for UTIs, which will also be briefly discussed with regards to IL-1β and NLRP3.
Inflammasomes and pyroptosis
The human genome encodes 22 NLRs with a characteristic tripartite domain structure consisting of a variable N-terminal domain, central NOD domain, and C-terminal leucine-rich repeats (LRR) domain. The NLRs are categorized into four distinct subfamilies based on the N-terminal effector domain present, which can be acidic transactivation domain (NLRA proteins), baculoviral-inhibitory repeat (BIR)-like domain (NLRB proteins), caspase recruitment domain (CARD) (NLRC proteins), and pyrin domain (NLRP proteins) 27 . Members NLRP1 and NLRP3, of the NLRP subfamily and NLRC4 of the NLRC subfamily assemble inflammasomes in response to specific ligands or upstream stimuli. AIM2, which belongs to the ALR family (also known as Pyrin and HIN domain (PYHIN) family), also forms an inflammasome upon sensing any double-stranded DNA (dsDNA) which is at least 80 bp in length [28] [29] [30] [31] [32] . Other NLRs, such as NLRP7 and NLRP12, have also been reported to assemble inflammasomes under specific conditions but these await further characterization [33] [34] [35] [36] . In the majority of cases, inflamma some assembly is dependent on ASC, an adaptor protein that is crucial for the recruitment of caspase-1 into the complex 37 . Activation of the inflammasome results in the cleavage of the enzyme pro-caspase-1 to its active form, which subsequently cleaves the precursor forms of inflammatory cytokines IL-1β and IL-18 . Inflammasome activation also triggers a type of inflammatory cell death known as pyroptosis, a process dependent on caspase-1-mediated cleavage of gasdermin D 41, 42 . Pyroptosis, which is morphologically distinct from apoptosis, is characterized by cell swelling followed by membrane rupture, which releases inflammatory cell contents into the extracellular milieu; these features are not observed during apoptosis, although caspase-8 and Fas-Associated protein with Death Domain (FADD) have overlapping functions in both the processes [43] [44] [45] [46] [47] . Pyroptosis, and production of IL-1β and IL-18 cytokines, are caspase-1-dependent and these two events coincide upon inflammasome activation, although -under certain conditions -cytokine secretion can also be observed without the induction of pyroptosis 43 . Whereas pyroptosis results in the elimination of the pathogen niche, IL-1β and IL-18 serve important proinflammatory and chemotactic functions including induction of adhesion molecules and influx of immune cells to the site of infection 43, 44, [48] [49] [50] .
Activation of the NLRP3 inflammasome NLRP3 is by far the most well characterized inflammasome complex, with vital roles in both infectious and inflammatory conditions. This inflammasome is triggered by a wide variety of microbial (lipopolysaccharide (LPS), bacterial haemolysins and toxins), endogenous (ATP, uric acid, cholesterol), and exogenous (silica, alum, asbestos) ligands [51] [52] [53] [54] , and requires two signals for its activation, at least in mouse macrophages 55, 56 . The first signal is provided by ligation of TLRs by microbial stimuli, which initiates the production of pro-IL-1β and NLRP3 via nuclear factor-κB (NF-κB) signalling and gene induction. The second signal is provided by PAMPs and DAMPs, which convene the NLRP3 assembly for processing pro-caspase-1. A noncanonical version of the NLRP3 inflammasome has also been described, which additionally involves caspase-11 functioning upstream for caspase-1 processing [57] [58] [59] . Assembly of the noncanonical caspase-11-dependent inflammasome is triggered in response to Gram-negative, but not Grampositive, bacterial infection in mouse macrophages [57] [58] [59] .
Key points
• The NLRP3 inflammasome is activated during infection with uropathogenic Escherichia coli (UPEC) in an α-haemolysin-dependent manner, and exaggerated activation of this inflammasome can cause symptomatic infection • Inflammasome-dependent pyroptosis promotes exfoliation of UPEC-infected urothelial cells, thereby resolving the infection and reducing the incidence of chronic cystitis; however, pyroptosis might also increase latency by permitting microbial access to deeper urothelial layers • Autophagy dampens IL-1β-release and endorses UPEC latency by promoting the establishment of quiescent intracellular reservoirs (QIRs), which are reduced in cells in which autophagy is defective • Group B Streptococcus activates the NLRP3 inflammasome, which is dependent on β-haemolysin-mediated lysosomal leakage and RNA escape; however, the mechanistic details remain unclear • IL-1β levels are markedly enhanced during acute pyelonephritis, and could serve as a diagnostic marker for acute pyelonephritis • Inflammasome activation and IL-1β secretion have important roles in various murine models of bladder inflammation, representing viable pharmaceutical targets Subsequent studies demonstrated direct sensing of LPS by murine caspase-11 leading to the activation of the noncanonical inflammasome 60 . Notably, caspase-11, even in the absence of the NLRP3 complex, can directly cleave downstream effector gasdermin D for induction of pyroptosis 41 (FIG. 1) . Humans lack caspase-11 but ortho logues caspase-4 and caspase-5 compensate for its absence by directly sensing LPS and inducing pyroptosis and IL-1β production [60] [61] [62] . Whereas a plethora of very different molecules are known to trigger canonical NLRP3, that such a wide variety of ligands are all able to bind NLRP3 directly is unlikely. Instead, these stimuli are thought to induce one or more downstream cellular events, which in turn prompt NLRP3 complex formation. The exact pathway of NLRP3 activation is yet to be elucidated, but several potential mechanisms have been proposed. These mechanisms include the release of cathepsins as a result of phagosomal membrane destabilization 52 , K + efflux 63, 64 , the production of mitochondrial reactive oxygen species (ROS) [65] [66] [67] , and release of mitochondrial DNA or cardiolipin 68, 69 . Undoubtedly, elucidation of the activation mechanisms is crucial to better understand the role of the NLRP3 inflammasome in infectious diseases. Equally, the key role of NLRP3 in inflammatory and autoimmune diseases cannot be ignored. Naturally occurring mutations in the NLRP3 are associated with the progression of autoinflammatory conditions known collectively as cryopyrin-associated periodic syndromes (CAPS), which are characterized by recurrent rash, fever and/or chills, conjunctivitis, and fatigue 70 . Besides CAPS, studies in the past decade have also implicated NLRP3 in many other inflammatory diseases, including type 2 diabetes, gout, atherosclerosis, rheumatoid arthritis, and inflammatory bowel disease 40, 51, 53, [71] [72] [73] . Thus, the NLRP3 inflammasome serves as a defence mechanism against invading pathogens, and its dysregulation might also be a contributing factor in the pathogenesis of inflammatory diseases. . A large percentage of UPEC strains also encode an inhibitory protein, TcpC, which can directly inhibit NLRP3 assembly formation. Group B Streptococcus also activates the NLRP3 inflammasome and this process is dependent on β-haemolysin-mediated lysosomal rupture. Whether the release of cathepsins augment inflammasome activation remains unknown, but NLRP3 activation by the released RNA has been observed. Pseudomonas aeruginosa activates the NLRC4 inflammasome by the introduction of flagellin and the presence of PscI, the inner rod protein of P. aeruginosa T3SS. IL-1β production is elevated upon infection with P. aeruginosa biofilms. Activation of inflammasomes also leads to caspase-1-mediated cleavage of gasdermin D, which triggers pyroptotic cell death. Notably, in the noncanonical inflammasome, caspase-11 can also directly cleave gasdermin D leading to pyroptosis without the assembly of the NLRP3 complex. IL-18, interleukin-18; IL-1β, interleukin-1β; NLRC4, nucleotide binding domain and leucine-rich repeat CARD domain-containing protein 4; NLRP3, nucleotide binding domain and leucine-rich repeat pyrin domain-containing protein 3; T3SS, Type III secretory system; TcpC, Toll/IL-1 receptor-containing (TIR-containing) protein C; TLR4, Toll-like receptor 4.
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The inflammasome and UPEC infection Innate immune responses during UPEC infection.
UPEC is estimated to cause up to 80% of all UTIs 2 . The pathogenesis of UPEC invasion in the urinary tract has been well characterized: UPEC adheres to specific receptors on the urothelium via type I fimbriae and a variety of surface associated adhesins. Although predominantly extracellular, several reports suggest that UPEC do invade superficial bladder epithelial and kidney epithelial cells and this internalization does not seem to be actively directed by the absence of any identified bacterial effectors [74] [75] [76] [77] . Once in the intracellular space, UPEC are thought to be harboured within specialized exocytic vesicles which -upon an increase in urine volume -fuse with the apical membrane of epithelial cells in a TLR4-triggered cAMP-dependent mechanism. This process is an important host defence mechanism leading to bacterial expulsion by the epithelial cells, and also performs a critical physiological function by providing the requisite membranes for bladder expansion 78 . UPEC can also elude expulsion by escaping into the cytoplasm, where they replicate within biofilm-like intracellular bacterial communities (IBCs) 79 . Thus, exfoliation of the UPEC-infected superficial epithelial cell layer is the predominant mech anism for termination of acute UPEC infection. However, exfoliation exposes deeper urothelial layers for invasion, wherein a subset of UPEC can establish themselves into quiescent intracellular reservoirs (QIRs). Such QIRs possess characteristics of a membrane-bound compartment and enable bacteria to survive for months 80, 81 . UPEC in QIRs remain refractory to systemic antibiotic therapy and serve as a source of recurrent UTI 81 . The innate immune responses to UPEC in the urinary tract have been extensively investigated 82 . Introduction of E. coli into the mammalian urinary tract elicits a robust inflammatory response resulting in the release of inflammatory cytokines such as TNFα and IL-6, in addition to the recruitment of neutrophils and macrophages 83, 84 . In UTI pathogenesis, this immune response is mainly dependent on TLRs, particularly TLR4, TLR5, and TLR11 (in mice) and downstream cytokines, such as IL-8 (REFS [85] [86] [87] [88] . Indeed, deficiency in Tlr4 and Tlr5 exacerbates urinary infection in experimental mouse models, highlighting the importance of these PRRs in UPEC recognition and immune activation 83, 86, 89 . Furthermore, humans with genetic mutations in these pathways are more susceptible to UTIs 16 , and polymorphisms in TLRs have also been associated with increased UTI susceptibility 90 . Thus, innate immune recognition of UPEC and other urinary pathogens by PRRs is vital for host clearance and resolution.
Activation and suppression of the inflammasome by UPEC. Our understanding of TLR-pathways that are critical to UTIs has been developing over the past few decades, but a role for inflammasome activation has only recently been highlighted in UPEC infections. Studies have previously shown that other strains of E. coli, such as enterohaemorrhagic E. coli, are able to activate the NLRP3 inflammasome 91 . In 2015, Schaale et al. 92 demonstrated that the pore-forming cytotoxin α-haemolysin of several strains of UPEC activates inflammasomes and induces cell death and IL-1β production in NLRP3-dependent manner (FIG. 1) . However, differences in inflammasome effector mechanisms were observed between human and mouse cells during infection with UPEC. Unlike mouse macrophages, induction of cell death in human monocyte-derived macrophages was reported to be NLRP3-independent. Consequently, exposure to NLRP3 inhibitor MCC950 resulted in no resistance to cell death in human macrophages 92, 93 . Additionally, the study showed that inflammasome activation between different strains of UPEC varied -those that did not activate the inflammasome were either highly drug-resistant or were associated with asymptomatic infection. By contrast, UPEC strains that did activate the inflammasome are those that cause symptomatic infections and are associated with urinary tract pathology 92 . Haemolysin is encoded by ~50% of UPEC isolates and, in agreement with the aforementioned findings, strains expressing this virulence factor cause more extensive damage to the urothelium during infection and can result in bladder haemorrhage 94, 95 . Consequently, α-haemolysin-expressing strains might contribute to severe infections and poor clinical outcomes in some patients. However, whether some of the UPEC strains have lost the ability to activate the inflammasome, or even developed means to inhibit it in order to avoid immune detection, remains to be determined. Nevertheless, inflammasome activation seems to contribute to the inflammatory pathology in several UPEC strains and might be responsible for the signs and symptoms observed in human cystitis.
Activation of the NLRP3 inflammasome by UPEC was also demonstrated in a 2016 study that identified a putative inflammasome inhibitor expressed by UPEC 96 . Infection of macrophages with UPEC CFT073 strain -which expresses a major virulence factor and a TLR-signalling inhibitory protein, Toll/IL-1 receptorcontaining (TIR-containing) protein C (TcpC) -triggered marginal NLRP3 assembly. CFT073 infection at low multiplicity of infection resulted in minimal IL-1β secretion, which increased dramatically upon infection with a mutant bacteria that was not expressing TcpC (ΔtcpC) (FIG. 1) . Mechanistically, TcpC dampened pro-caspase-1 processing and, therefore, IL-1β production, by chelating directly with NLRP3 and caspase-1, thereby effectively prohibiting the NLRP3 complex formation 96 . In a mouse model of UTI, challenge with CFT073 ΔtcpC resulted in elevated urinary IL-1β secretion compared with mice infected with the wild-type CFT073 UPEC strain, suggesting that TcpC dampens multiple immune pathways. The role of the NLRP3 inflammasome against UPEC infection remains to be fully determined; however, it seems that IL-1β might contribute to host defence, as urine of IL-1β-deficient mice have been shown to contain higher bacteria titres 96 . Thus, inhibition of NLRP3-dependent IL-1β production by TcpC might be beneficial to UPEC during bladder infection, and could help establish acute cystitis in patients. Whether this response is common to all strains of UPEC is yet to be determined. However, 40-50% of UPEC strains isolated from patients with pyelonephritis and ~20% of UPEC strains isolated from patients with cystitis are known to harbour the tcpC gene 97, 98 . Hence, the frequency of TcpC-positive UPEC isolates seems to correlate with the severity of the urinary tract disease. However, whether the expression of UPEC TcpC varies depending upon the site of infection is not known; thus, identification of the conditions in which TcpC-dependent inflamma some inhibition might be most relevant during urinary infection has yet to be established.
Inflammasome-mediated pyroptosis promotes urothelium exfoliation. Despite its aforementioned detrimental role, α-haemolysin and inflammasome-dependent pyroptosis has been suggested to be advantageous to the host in the early response to UPEC; α-haemolysin has been observed to activate caspase-1 and caspase-4, leading to pyroptosis of urothelial cells 99 . Exfoliation and regeneration of the urothelium is thought to eliminate adherent IBCs 77, 100 . The shedding of urothelial cells is dependent on caspases 77 , and additionally relies on serine proteases to degrade cytoskeletal scaffold proteins 101 . Some studies have highlighted a role for NLRP3 and IL-1β in this response. Indeed, overexpression of α-haemolysin has been shown to trigger NLRP3-dependent urothelial cell death, which was inhibited in the presence of the caspase-1 and caspase-4 inhibitor Ac-YVAD-CHO 99 (FIG. 2) . This overexpression reduced the incidence of chronic cystitis, indicating that exfoliation of the urothelium serves to eliminate UPEC and, therefore, prevent bacterial persistence 99 . By contrast, exfoliation might infrequently enable UPEC to attach to and invade the exposed urothelial layers 102 (FIG. 2) . In support of this hypothesis, studies have demonstrated that inhibition of caspase-1/11 is protective against chronic cystitis in mouse models of UPEC superinfection 103 . Superinfection, or repeat introduction of bacteria, augments the risk of chronic cystitis, and partly explains the increased risk of UTI observed with frequent sexual intercourse, which reintroduces bacteria from periurethral flora into the urinary tract. Thus, caspase-1-dependent and caspase-11-dependent exfoliation might have a role in predisposition to recurrent UTI infection. Overall, these studies suggest that inflammasome-dependent pyroptosis promotes urothelial exfoliation, which can enable clearance or latency. Additionally, exfoliation might also be promoted by caspase-3-dependent apoptosis, which further contributes to the defence mechanisms against bacterial attachment and invasion 77, 104 . Thus, urothelium exfoliation is supported by distinct cell death pathways. Intriguingly, compromised barrier integrity at the time of exfoliation might also permit unresolved UPEC infection access to the underlying urothelial layers. Nature Reviews | Urology Autophagy and the inflammasome in UPEC clearance and latency. Autophagy is an intracellular degradation system that enables the cell to recycle cytosolic components such as damaged organelles and proteins. In the past decade, data have also suggested autophagy as a major mechanism for the removal of intracellular pathogens, in addition to its role in the inflammatory process and the adaptive immune response 66, [105] [106] [107] [108] . Activation of autophagy (macroautophagy) is a multistage process that begins with the formation of a membrane phagophore that elongates to a preautophagosomal structure and finally matures into an autophagolysosome. Each stage of autophagosome elaboration requires concerted effort of a number of autophagy-related proteins. The ATG12-ATG5-ATG16L1 complex and the LC3 lipidation system are critical for expansion and closure of the autophagosomal membrane structure, and deficiency in any of the molecules in these pathways leads to defective autophagic degradation 109, 110 . Additionally, common polymorphisms in the human ATG16L1 gene have been associated with enhanced inflammation and inflammatory bowel disease 111, 112 . By employing genetic tools lacking key components of the autophagosome formation, a vital role for autophagy has been demonstrated in microbial clearance, inflammasome activation, and IL-1β production 113 . A role for autophagy has also been proposed in UPEC infection 114, 115 . Mice carrying an Atg16l1 hypomorphic allele (Atg16L1 HM ), which causes reduced ATG16L1 expression, cleared UPEC more effectively than wild-type mice, indicating a detrimental role of autophagy in this infection. Furthermore, ATG16L1 expression was found to be critical for bacterial clearance in radiosensitive cells of the haematopoietic compartment, with macrophages carrying the defective allele (Atg16L1 HM macrophages) demonstrating increased bacterial uptake at 1 h postinfection. Intriguingly, a similar pattern of decrease in UPEC colony counts was observed at later times postinfection suggesting that the dynamics of bacterial killing are not altered and that Atg16L1 HM macrophages enhance UPEC degradation by increasing internalization during the early stages of infection. These data suggest that enhanced uptake and increased IL-1β production by macrophages inept at autophagy could both work in conjunction to impact UPEC clearance.
In addition to processing damaged organelles and infectious agents, specific autophagic pathways have been demonstrated to target ubiquitylated inflamma somes and pro-IL-1β for degradation 116, 117 . In agreement with this observation, Atg16l1 HM macrophages and mice secreted more IL-1β, which was dependent on the NLRP3 inflammasome as shown by absence of IL-1β production by Nlrp3-deficient macrophages. Atg16L1 HM macrophages also had key roles in UPEC clearance in vitro and in mice transurethrally infected with UPEC 114, 115 . Consequently, treatment with anakinra, an IL-1 receptor antagonist (IL-1Ra), abrogated protection against UPEC in Atg16L1 HM mice. Besides suggesting an important role of IL-1β signalling in UPEC clearance, these data add to increasing evidence that autophagy might help to dampen excessive inflammatory responses. By contrast, in other models of infection and inflammation, defective autophagic function might be detrimental. In particular, defective autophagy was shown to enhance susceptibility to bacterial infection and worsened dextran sulfate sodium (DSS)-induced acute colitis 108, 113, 118 . Thus, the role of autophagy in UPEC colonization might be specific to the pathogen and the experimental model used. Indeed, the above response was not observed in Atg16L1
HM macrophages infected with commensal E. coli, which displayed compar able invasion and growth. Another argument favouring the detrimental role of autophagy in UPEC infection is supported by the apparent function of autophagy in promoting UPEC persistence. UPEC establishes latency in membrane-bound QIRs and these were found to be less abundant in the epithelial cells of Atg16l1-deficient mice than in wild-type mice 115 . This observation implies that UPEC survive in autophagy-competent cells by establishing QIRs (FIG. 3) , although whether UPEC hijacks some of the pre-existing autophagosomes to gain this advantage remains unclear. Overall, the data indicate a role for autophagy in the persistence of UPEC, with the loss of Atg16l1 preventing UPEC latency. Thus, reduced persistence and enhanced inflammasome activation observed in Atg16l1-deficiency could potentially work together to alleviate UTI burden. We can speculate that IL-1β signalling might, intriguingly, have a direct role in the destabilization of QIRs. Although the associated detrimental features of lack of autophagic process on mammalian development and immunity against intracellular pathogens cannot be ignored, these studies suggest that humans with naturally occurring mutations in ATG16L1 might have an advantage in their ability to resolve UPEC infection.
The NLRP3 inflammasome and GBS Group B Streptococcus (GBS), or Streptococcus agalac tiae, is a Gram-positive bacterium and a leading cause of disease in neonates, pregnant women, and immunocompromized individuals [119] [120] [121] [122] [123] . A limited number of serotypes are associated with invasive infection, and cervicovaginal colonisation can result in perinatal transmission from mother to child during pregnancy. Several GBS serotypes are also associated with UTIs, and cause bacteraemia, cystitis, and pyelonephritis 124, 125 . Predisposing factors for urinary GBS infection include diabetes mellitus and chronic renal failure 124 . The innate immune system has an important role in anti-GBS host defences in vivo, and has been shown to induce the production of proinflammatory cytokines TNFα and Type I interferons 126, 127 . Studies have begun to highlight the importance of inflamma some activation and signalling in GBS infections -Ulett et al. 122 first highlighted the induction of IL-1α and IL-1β in the initial stages of GBS urinary infections in mice. The role of IL-1α in inflammasome-mediated responses has not been fully established; however, its secretion has been shown to coincide with IL-1β following stimulation with known inflammasome activators 128 . This secretion was shown to occur both in an NLRP3-dependent and inflammasomeindependent manner 128 . Challenge with uropathogenic GBS induced robust production of IL-1β in mice, to an extent similar to that seen upon infection with UPEC.
Interestingly, IL-1α production in response to GBS was considerably higher than that induced by UPEC, and could be induced by both uropathogenic and nonuropathogenic GBS strains 122 , indicating that the response might be unique to this pathogen. Alternatively, reduced IL-1α secretion following UPEC infection might be due to the ability of this pathogen to suppress some of the inflammatory pathways in order to avoid innate immune responses 129 . The critical role for the NLRP3 inflammasome in vivo was described by a subsequent study, in which mice deficient in core components of the NLRP3 complex showed enhanced mortality concomitant with elevated GBS burden in the blood and kidneys of intraperitoneally-infected mice 130 . Similarly, a separate study demonstrated increased susceptibility of Il1r-deficient mice to GBS infection 131 . Collectively, these studies indicate that inflammasome activation by GBS is not only important in the initial inflammatory response but is also required to control the infection in vivo.
The mechanism of NLRP3 activation during GBS infections has been examined in detail. GBS is able to induce both the synthesis of pro-IL-1β, and secretion of IL-1β and IL-18 cytokines in bone-marrow-derived macrophages and dendritic cells, with increased cytokine production observed in dendritic cells 130 . Although live GBS has previously been shown to induce type-I interferon production following release of GBS DNA in the cytosol 132 , IL-1β secretion by GBS was absolutely dependent on the NLRP3 inflammasome with no role observed for the DNA-triggered AIM2 inflammasome 130 . Furthermore, activation of the NLRP3 inflammasome by GBS is dependent on β-haemolysin, as GBS strains lacking this toxin were unable to process pro-caspase-1 or secrete IL-1β (FIG. 1) . By contrast, infection with hyperhaemolytic GBS strains resulted in enhanced IL-1β secretion 133 . This study also emphasized the importance of β-haemolysin-mediated lysosomal leakage in inflammasome activation following interaction between GBS RNA and cytosolic NLRP3 (REF. 133) (FIG. 1) . Accordingly, transfection of biotinylated-RNA co-precipitated more NLRP3 from cells infected with GBS NEM 316 wild-type strain than following infection with β-haemolysin-deficient NEM 2459 strain 133 . These experiments suggest the indispensable nature of β-haemolysin-mediated lyso somal damage in NLRP3 inflammasome activation by GBS, although the direct contribution of lysosomal cathepsins needs reassessment. Moreover, NLRP3 has never been demonstrated to bind RNA directly, and DExD/H-box RNA helicase family members -particularly DDX19A and DHX33 -have been proposed to mediate this interaction 134, 135 . Overall, further studies are needed to determine the precise activation mechanisms of inflamma somes and their effect on disease pathogenesis during GBS infection of the urinary tract.
The NLRC4 inflammasome and P. aeruginosa Risk factors for infections with non-UPEC organisms include recurrent UTIs, the presence of foreign bodies, obstruction, urinary catheters, and male gender 136 . Pseudomonas aeruginosa is the third most common infectious agent associated with nosocomial catheterassociated UTIs, in addition to causing a variety of other acute infections 137, 138 . Owing to their ability to form biofilms on the surface of catheters, P. aeruginosa are able to access and colonize the bladder. In addition, they pose a clinical challenge, as such biofilms are often resistant Nature Reviews | Urology to host defence mechanisms and antimicrobial agents 139 , leading to persistent infections and an overall habitat that fosters establishment of antimicrobial-resistant strains 140, 141 . NLRC4 forms a well-characterized inflammasome by interacting with caspase-1, inducing the production of IL-1β, and leading to cell death via pyroptosis 142 . Studies have shown that Gram-negative bacteria such as Legionella pneumophila and Salmonella typhimurium are able to activate the NLRC4 inflammasome, which was later attributed to detection of flagellin in the cytoplasm [143] [144] [145] [146] . Further studies demonstrated that NLRC4 could also be activated via type III secretory system (T3SS), which is used to inject effector proteins into the cytoplasm, thereby enhancing bacterial virulence 37, 147, 148 . P. aeruginosa has been shown to activate the NLRC4 in a manner similar to L. pneumophila and S. typhimu rium via introduction of flagellin into the cytoplasm, a process that is dependent on the T3SS 149 . Later studies revealed that distinct neuronal apoptosis inhibitory protein (NAIP) family members -NLR proteins that contain a BIR domain -are the true cytosolic receptors that act upstream of NLRC4 to trigger this complex. NAIP5 and NAIP6 recognize the cytosolic presence of flagellin, whereas NAIP1 and NAIP2 recognize bacterial needle and inner rod proteins of the T3SS, respectively 150, 151 . Rod proteins from the T3SS apparatus, such as protein PrgJ from S. typhimurium, share a similar secondary structure to the D0 domain of flagellin, which is the domain responsible for activation of NLRC4 (REFS 152, 153) . However, flagellin-deficient strains of P. aeruginosa also activate the NLRC4 inflammasome, suggesting the presence of other NAIP-NLRC4 triggers 154 . This activation was attributed to the T3SS inner rod protein PscI of P. aeruginosa (FIG. 1) , which is homologous to Salmonella PrgJ 153 . Additionally, pilin, the major component of type IV pilus of P. aerugi nosa, has been suggested to activate NLRC4 leading to IL-1β secretion 155 . Inflammasome activation has been examined in a lung model of acute P. aeruginosa pneumonia, whereby activation of the NLRC4 was associated with increased lung pathology, cell death, and impairment of microbial clearance 156 . The increased pathology in the lung diminished upon infection with P. aeruginosa mutants that lacked flagellin b (ΔfliC) or in Nlrc4deficient mice infected with wild-type strain. In accordance with these data, mice deficient in Il1r cleared lung infection rapidly compared with control wild-type mice 157 . These studies suggest that reduced inflamma some signalling might be beneficial for P. aeruginosa clearance and immune homeostasis in the lung tissue.
Similar detrimental roles of IL-1β have been observed in a mouse model of ascending pyelonephritis following infection with P. aeruginosa. Elevated levels of IL-1β were observed in both the urine and renal tissue starting at day 1 postinfection which peaked at day 5 (REF. 158 ). Intriguingly, mice infected with biofilm cells of P. aerugi nosa produced more IL-1β (and TNFα) than those infected with planktonic bacteria. This increased IL-1β level correlated with the influx of neutrophils, but the recruited neutrophils did not contribute to resolution of infection. Instead, higher bacteria titres were found in mice infected with biofilms, suggesting that biofilms are resistant to neutrophil-mediated cell death 158 . Closer histopathological evaluation showed that increased neutro phil infiltration was associated with severe inflammation in the renal tissue along with shedding of cells and vascular permeability in biofilm-infected mice. Thus, enhanced IL-1β could, once again, be implicated in the pathogenesis of P. aeruginosa infections. As this study also demonstrated elevated levels of TNFα, inflammasomeindependent effects of IL-1β on the renal tissue cannot be excluded.
Whether P. aeruginosa major virulence factor, flagellin, could be used for protection against ascending infection of the urinary tract has also been investigated. Immunisation of mice with non-adjuvanted flagellin 'b' , which is encoded by the fliC gene and does not undergo antigenic variation, correlated with reduced pro inflammatory cytokine production in mice subsequently infected with P. aeruginosa compared with control unimmunized mice 159 . Consequently, immunized mice also displayed enhanced clearance of the bacteria in renal tissue, which was associated with improved gross morphology of kidney sections. In addition, neutrophil recruitment to the kidney seemed to fade after the second, booster dose of flagellin b, and the kidney tissue displayed no signs of any degradation or inflammation compared with increased inflammation observed in unimmunized mice 159 . Thus, vaccination with flagellin in this context seems to limit inflammation and help prevent UTI infection. Whether this represents a viable target for prophylactic therapy, particularly in the setting of recurrent UTIs, remains to be determined.
IL-1β as a marker in acute pyelonephritis
Acute pyelonephritis is a severe infection of the kidney and can lead to long-term local and systemic effects, including renal scarring and hypertension, especially in children 160, 161 . Acute pyelonephritis is also a major cause of end-stage renal failure; thus, prompt diagnosis and accurate treatment is key. However, clinical diagnosis of acute pyelonephritis can be difficult as symptoms are similar to those experienced during severe infection of the lower urinary tract, such as urinary frequency, urgency, and dysuria. Patients with acute pyelonephritis can also experience nausea, vomiting, fever, flank pain, and general malaise 162 . As with other bacterial infections, an increase in leukocyte counts, neutrophil counts, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) values can help to differentiate acute pyelo nephritis from a severe lower UTI, but with varying sensitivity and specificity 163 . IL-1β production has been proposed as a marker to discriminate between acute pyelonephritis and lower UTIs 163 . Numerous clinical studies have demonstrated increased production of IL-1β in acute pyelonephritis and other urinary infections [164] [165] [166] , although patients with acute pyelonephritis seem to have considerably higher levels of IL-1β in their urine than patients with lower UTI 163, 166 . A similar increase in IL-1β levels has been observed in the serum of patients with acute pyelo nephritis, and the elevated cytokine level, in both serum and urine, returns to normal following antibiotic therapy. These findings also corroborate with studies conducted in the late 1990s that reported increased IL-1β mRNA levels in the kidneys of mice infected with E. coli and subjected to urethral obstruction 167 . Additionally, studies in a mouse model of experimental pyelo nephritis, in which infection was initiated by urethral catheterization, suggest a favourable role for IL-1β, as deficient mice displayed more frequent and widespread inflammatory changes than their wild-type counterparts 48 h after infection. Similarly, although IL-1β is important for the induction of inflammatory mediators and might, therefore, be expected to promote renal scarring, the cytokine was unexpectedly found to reduce scarring, which increased in mice lacking Il1β 168 . Remarkably, these effects were due to the enhanced production of neutrophil chemoattractant MIP2 (also known as CXCL-2) in Il1β deficient mice 168 . The increased influx of neutrophils might, therefore, have a role in the inflammatory changes seen in Il1βdeficient mice following acute pyelonephritis. These studies suggest that IL-1β promotes not only proinflammatory chemokines, but might also induce anti-inflammatory mediators. Additionally, these data suggest an important role for IL-1β in the initial stages of pyelonephritis. Although cleavage -and thus maturation -of pro-IL-1β to its bioactive form depends on caspase-1 in the inflammasome, inflammasomeindependent pathways of IL-1β processing have been suggested. These include neutrophil-derived and macrophage-derived serine proteases such as proteinase 3, elastase, cathepsin G, and chymotrypsin, among others 169, 170 . Whether IL-1β production in pyelonephritis is indeed dependent on inflammasome activation or is processed by a caspase-1-independent mechanism has not been examined. Similarly, whether renal tubular cells possess an enhanced propensity for inflammasome activation or IL-1β production is not known. Taken together, these studies indicate the central role for IL-1β in the acute inflammatory response to a variety of urinary pathogens and potential for IL-1β levels to be used as a diagnostic marker to distinguish between severe lower UTI and acute pyelonephritis.
NLRP3 as a pharmacological target
Inflammation of the bladder, or cystitis, is a contributing factor in many bladder-associated pathologies. The most common bladder-associated conditions are UTIs, although the bladder is also susceptible to sterile inflammation induced by bladder outlet obstruction, bladder stones, chemotherapy treatment, and chronic inflammation caused by conditions such as interstitial cystitis 171 . These conditions share similar symptoms, with frequency, urgency, and pelvic pain being common, making it difficult to distinguish them from complicated interstitial cystitis. Whether these diseases converge on common inflammatory pathways is yet to be established; however, research has focused on the contributing factors of the innate immune system, in particular the role of TLRs and NLRs. NLRs are expressed in the bladder, and particularly NLRP3, NLRC4, and key inflamma some components such as ASC, were demonstrated to be expressed in the bladder urothelia 25 . In agreement with their roles, introduction of NLRP3-specific and NLRC4-specific PAMPs and DAMPs into the bladder lumen of mice induced the activation of these receptors resulting in procaspase-1 processing 25 . Again, these results demonstrate the ability of the urothelium to mount an inflammatory response to pathogens, in particular to flagellin, which is a common virulence factor among uropathogens 172 . LPS is also an important virulence factor of uropathogens 173 , and NLRP3 activation has been shown to have a role in an LPS-induced rat model of cystitis 174 . LPS injected directly into the bladder epithelium (in order to bypass the protective barrier of glycosaminoglycan layer which lines the bladder lumen) elicited increased caspase-1 activation in the urothelium and elevated levels of IL-1β in the urine compared with control rats injected with saline. In these experiments, levels of IL-1β were detectable in the urine 24 h after LPS exposure, which is in accordance with separate studies showing the production of Il1β mRNA in the bladder in the cystitis model 174, 175 . Furthermore, inhib ition by glyburide, a NLRP3 inflammasome inhibitor, attenuated levels of both caspase-1 activation and IL-1β production 174 . Additionally, glyburide treatment reduced bladder weight and extravasation of Evans blue dye into bladder tissue, two well-documented indices of bladder inflammation, which were increased in rats treated with LPS alone 174 . Moreover, exposure to LPS (and also saline), reduced void volume and intercontraction intervals; these parameters were restored upon treatment with glyburide. In addition, voiding pressure and threshold pressure also decreased upon LPS injection, although only the former was found to be NLRP3-dependent 174 . These data indicate that inflammasome activation might have a role in bladder dysregulation; however, its exact role in urodynamic changes, particularly in humans, warrants further investi gation. Similar to the above study, NLRP3 activation was also observed in a cyclophosphamideinduced rat model of cystitis 25 . Although no infectious agent is involved in this model, the cyclophosphamide metabolite acrolein induces necrosis and apoptosis in urothelia resulting in the generation of DAMPs that trigger NLRP3. Collectively, these data indicate a role for the NLRP3 inflammasome in induction of inflammation within the bladder, regardless of the nature of the trigger. Glyburide, which is a sulfonyl urea drug approved for the treatment of diabetes, is also an NLRP3 inflamma some inhibitor and represents a viable pharmacological agent to target bacterial cystitis. However, the precise functions of inflammasomes are context dependent. Thus, whether these results are also faithfully recapitulated during actual infection by uro pathogens needs to be investigated before the translational potential of targeting inflammasomes can be exploited.
Conclusions
UTIs remain a major health problem worldwide, and recur in ~25% of all patients. The cellular architecture of the urinary tract, which is enforced with tight epithelial barriers, is assembled to oppose pathogen invasion. In addition, the mild antiseptic properties of urine contribute to inhibition of microbial growth. Although most microorganisms do not survive, some of them can colonize and cause infection in the urinary tract. The innate immune responses to uropathogens are chiefly mediated by TLRs and NLRs. In particular, the roles of inflammasome-assembling NLRs in UTIs are becoming apparent, and continuous evaluation of their therapeutic potential is vital as we make further progress in understanding their role. Several questions remain, including whether inflammasomes can be targeted for treatment of UTIs, the nature of the possible approaches, and whether we should focus on the direct inhibition of inflammasome assembly, or target downstream effector signalling. Our current state of understanding requires considerable expansion before these questions can be answered. Inflammasome activation leads to processing of biologi cally inactive forms of cytokines IL-1β and IL-18. In patients with UTIs, elevated IL-1β levels in the urine had been recognized for some time; however, the precise role of this cytokine in the pathogenesis of UTIs remains enigmatic. Studies over the past two decades have indicated vital roles of IL-1β in resolving UTI and in dampening inflammatory changes in the kidney. Meanwhile, lack of Il1β is linked to elevated renal scarring in mouse models of experimental pyelonephritis. Whether IL-1β secretion in these studies is absolutely dependent on inflammasomes is not known. By contrast, activation of the NLRP3 inflammasome in the murine bladder epithelium enhances inflammatory pathology. Thus, the variability in these studies needs to be addressed to in order to develop inflammasomes as a potential pharmacological target.
Drugs that directly target inflammasomes have been identified. The type 2 diabetes drug glyburide is a specific NLRP3 inhibitor and abrogates pathology in a mouse model of UTI 174 . Likewise, a compound, MCC950, has been found to selectively inhibit both the canonical and non-canonical NLRP3 inflammasomes 93 . However, these drugs inhibit all inflammasome functions, and, inflammasomes have both favourable and detrimental roles. Consequently, design of therapeutics targeting each of the distinct inflammasome functions is imperative to enable systematic management and treatment of UTIs while still retaining the inflammasome-dependent host-beneficial functions. Furthermore, a comprehensive portrayal of the NLR responses in the urinary tract is required in order to design improved therapeutics.
Finally, an emerging theme from the studies is that a balance of inflammasome activation is key for effective response to uropathogens. Understanding the fundamental mechanisms that regulate inflammasomes in the urinary tract and the impact of inflammasome signalling in disease pathogenesis during UTIs should be the ultimate goal of future studies.
